Cite
van Leeuwen NM, Boonstra M, Bakker JA, et al. Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis. Arthritis Rheumatol. 2021;73(12):2338-2347doi: 10.1002/art.41814.
van Leeuwen, N. M., Boonstra, M., Bakker, J. A., Grummels, A., Jordan, S., Liem, S., Distler, O., Hoffmann-Vold, A. M., Melsens, K., Smith, V., Truchetet, M. E., Scherer, H. U., Toes, R., Huizinga, T. W. J., & de Vries-Bouwstra, J. K. (2021). Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis. Arthritis & rheumatology (Hoboken, N.J.), 73(12), 2338-2347. https://doi.org/10.1002/art.41814
van Leeuwen, Nina M, et al. "Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis." Arthritis & rheumatology (Hoboken, N.J.) vol. 73,12 (2021): 2338-2347. doi: https://doi.org/10.1002/art.41814
van Leeuwen NM, Boonstra M, Bakker JA, Grummels A, Jordan S, Liem S, Distler O, Hoffmann-Vold AM, Melsens K, Smith V, Truchetet ME, Scherer HU, Toes R, Huizinga TWJ, de Vries-Bouwstra JK. Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis. Arthritis Rheumatol. 2021 Dec;73(12):2338-2347. doi: 10.1002/art.41814. Epub 2021 Nov 02. PMID: 34042326.
Copy
Download .nbib